Telangana DCA Seizes Overpriced ‘ICONE-200’ At Pharmacy In Quthbullapur

Hyderabad: The Drugs Control Administration, Telangana seized antifungal medicine ‘ICONE-200 Capsules’ (Itraconazole Capsules 200 mg) at Quthbullapur Village, Medchal-Malkajgiri district for over-pricing.

According to the DCA officials, the MRP indicated is very high compared to the ceiling price fixed for the product by the central government.

Upon information, the DCA raided a medical shop located in Quthbullapur Village, Medchal-Malkajgiri district on Monday, July 22.

The product Itraconazole Capsules 200 mg sold under the brand name ‘ICONE-200 Capsules’ is under price control as per Drugs (Prices Control) Order, 2013 and the price of the product shall be as per the ‘Ceiling Price’ fixed by National Pharmaceutical Pricing Authority (NPPA), government of India.

The Central government has set the ceiling price for Itraconazole Capsules 200 mg at Rs 22.12 per capsule, based on the Wholesale Price Index (WPI). However, Mascot Health Series Private Limited is selling the product for Rs 441.24 for a pack of 10 capsules, which amounts to Rs 44.12 per capsule. This pricing violates the Drugs (Prices Control) Order, 2013.

Mascot Health Series Private Limited which is marketing the product selling for Rs 441.24 for 10 capsules i.e. Rs. 44.12 per one capsule, on the label of the product which is a violation of Drugs (Prices Control) Order, 2013.

“The firm overpriced the product. The firm charged an excess of Rs 193.5 for 10 capsules,” said DCA officials.

Further investigation will be carried out and action shall be taken as per the law against all the offenders.

Related Posts

  • Pharma
  • September 16, 2024
  • 30 views
All Doctors To Have Unique IDs; NMC Starts Registration On Its New Portal

New Delhi: The National Medical Commission (NMC) has initiated the process of registration of all MBBS doctors eligible to practice in India on a recently launched portal, as a part of…

  • Pharma
  • September 16, 2024
  • 51 views
ICMR Signs MoAs To Advance First-In-Human Clinical Trials For Four Promising Molecules

New Delhi: In a significant stride towards strengthening India’s clinical research ecosystem, the Indian Council of Medical Research (ICMR) has formalized Memorandum of Agreements (MoAs) with multiple sponsors under its Network…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

All Doctors To Have Unique IDs; NMC Starts Registration On Its New Portal

All Doctors To Have Unique IDs; NMC Starts Registration On Its New Portal

ICMR Signs MoAs To Advance First-In-Human Clinical Trials For Four Promising Molecules

ICMR Signs MoAs To Advance First-In-Human Clinical Trials For Four Promising Molecules

Balaji Action Hsopital now equipped with Robotic System to Revolutionize Surgery

Balaji Action Hsopital now equipped with Robotic System to Revolutionize Surgery

1680 Onerex Cough Syrup Bottles Loaded In A Luxury Car Seized, One Arrested

1680 Onerex Cough Syrup Bottles Loaded In A Luxury Car Seized, One Arrested

DCC Once Again Sensitises State Regulators To Submit NSQ Data On Time

DCC Once Again Sensitises State Regulators To Submit NSQ Data On Time

DRI seizes alprazolam tablets worth Rs 30 lakh

DRI seizes alprazolam tablets worth Rs 30 lakh